Literature DB >> 33840423

Critical Appraisal of Systematic Reviews With Costs and Cost-Effectiveness Outcomes: An ISPOR Good Practices Task Force Report.

Olena Lena Mandrik1, J L Hans Severens2, Ariel Bardach3, Salah Ghabri4, Candyce Hamel5, Tim Mathes6, Luke Vale7, Torbjørn Wisløff8, Jeremy D Goldhaber-Fiebert9.   

Abstract

Year:  2021        PMID： 33840423     DOI： 10.1016/j.jval.2021.01.002

Source DB:  PubMed          Journal:  Value Health        ISSN： 1098-3015            Impact factor:   5.725


× No keyword cloud information.
  16 in total

1.  Out of Date or Best Before? A Commentary on the Relevance of Economic Evaluations Over Time.

Authors:  Gemma E Shields; Becky Pennington; Ash Bullement; Stuart Wright; Jamie Elvidge
Journal:  Pharmacoeconomics       Date:  2021-12-06       Impact factor: 4.981

2.  Cost-effectiveness of metabolic surgery for the treatment of type 2 diabetes and obesity: a systematic review of economic evaluations.

Authors:  Karen Jordan; Christopher G Fawsitt; Paul G Carty; Barbara Clyne; Conor Teljeur; Patricia Harrington; Mairin Ryan
Journal:  Eur J Health Econ       Date:  2022-07-22

3.  Methods and Study Design for Cancer Health Economics Research: Summary of Discussions From a Breakout Session.

Authors:  Henry J Henk; Ya-Chen Tina Shih; Bijan J Borah
Journal:  J Natl Cancer Inst Monogr       Date:  2022-07-05

Review 4.  Methodological Approaches to Cost-Effectiveness Analysis in Saudi Arabia: What Can We Learn? A Systematic Review.

Authors:  Fatma Maraiki; Shouki Bazarbashi; Paul Scuffham; Haitham Tuffaha
Journal:  MDM Policy Pract       Date:  2022-03-21

Review 5.  Trimming the fat: is there a health economic case for the use of new lipid-lowering drugs in chronic kidney disease? A scoping review.

Authors:  Alexandra Gallagher; Blaise Agresta; Brendan Smyth; Meg Jardine; Charles Ferro; Rachael L Morton
Journal:  Clin Kidney J       Date:  2021-12-24

6.  Population-Based Testing for Undiagnosed Hepatitis C: A Systematic Review of Economic Evaluations.

Authors:  Paul G Carty; Christopher G Fawsitt; Paddy Gillespie; Patricia Harrington; Michelle O'Neill; Susan M Smith; Conor Teljeur; Mairin Ryan
Journal:  Appl Health Econ Health Policy       Date:  2021-12-06       Impact factor: 3.686

7.  Tuberculosis screening costs and cost-effectiveness in high-risk groups: a systematic review.

Authors:  H Alsdurf; B Empringham; C Miller; A Zwerling
Journal:  BMC Infect Dis       Date:  2021-09-08       Impact factor: 3.090

8.  Diagnostics and Treatments of COVID-19: A Living Systematic Review of Economic Evaluations.

Authors:  Jamie Elvidge; Ashley Summerfield; David Nicholls; Dalia Dawoud
Journal:  Value Health       Date:  2022-02-16       Impact factor: 5.101

Review 9.  The economics of vision impairment and its leading causes: A systematic review.

Authors:  Ana Patricia Marques; Jacqueline Ramke; John Cairns; Thomas Butt; Justine H Zhang; Iain Jones; Marty Jovic; Allyala Nandakumar; Hannah Faal; Hugh Taylor; Andrew Bastawrous; Tasanee Braithwaite; Serge Resnikoff; Peng T Khaw; Rupert Bourne; Iris Gordon; Kevin Frick; Matthew J Burton
Journal:  EClinicalMedicine       Date:  2022-03-22

10.  Nurse staffing and patient care outcomes: protocol for an umbrella review to identify evidence gaps for low and middle-income countries in global literature.

Authors:  Abdulazeez Imam; Sopuruchukwu Obiesie; Jalemba Aluvaala; Michuki Maina; David Gathara; Mike English
Journal:  Wellcome Open Res       Date:  2022-05-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.